Clinical Trial Update: Botulinum Toxin in Burning Mouth Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating botulinum toxin for Burning Mouth Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Presidio Ospedaliero Garibaldi-Centro | Conditions: Burning Mouth Syndrome | Phase 2 | Status: COMPLETED